| 000 | 01708 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513101617.0 | ||
| 264 | 0 | _c19961127 | |
| 008 | 199611s 0 0 eng d | ||
| 022 | _a0306-5251 | ||
| 024 | 7 |
_a10.1111/j.1365-2125.1996.tb00166.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHe, G W | |
| 245 | 0 | 0 |
_aPotential greater than additive vasorelaxant actions of milrinone and nitroglycerin on human conduit arteries. _h[electronic resource] |
| 260 |
_bBritish journal of clinical pharmacology _cFeb 1996 |
||
| 300 |
_a101-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _a15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMammary Arteries _xdrug effects |
| 650 | 0 | 4 | _aMilrinone |
| 650 | 0 | 4 |
_aNitroglycerin _xpharmacology |
| 650 | 0 | 4 |
_aPhosphodiesterase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aPotassium _xpharmacology |
| 650 | 0 | 4 |
_aProstaglandin Endoperoxides, Synthetic _xpharmacology |
| 650 | 0 | 4 |
_aPyridones _xpharmacology |
| 650 | 0 | 4 |
_aThromboxane A2 _xanalogs & derivatives |
| 650 | 0 | 4 |
_aVasoconstrictor Agents _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aVasodilator Agents _xpharmacology |
| 700 | 1 | _aYang, C O | |
| 700 | 1 | _aGately, H | |
| 700 | 1 | _aFurnary, A | |
| 700 | 1 | _aSwanson, J | |
| 700 | 1 | _aAhmad, A | |
| 700 | 1 | _aFloten, S | |
| 700 | 1 | _aWood, J | |
| 700 | 1 | _aStarr, A | |
| 773 | 0 |
_tBritish journal of clinical pharmacology _gvol. 41 _gno. 2 _gp. 101-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2125.1996.tb00166.x _zAvailable from publisher's website |
| 999 |
_c8832624 _d8832624 |
||